Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H8O2 |
Molecular Weight | 136.1479 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)OC1=CC=CC=C1
InChI
InChIKey=IPBVNPXQWQGGJP-UHFFFAOYSA-N
InChI=1S/C8H8O2/c1-7(9)10-8-5-3-2-4-6-8/h2-6H,1H3
Molecular Formula | C8H8O2 |
Molecular Weight | 136.1479 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Phenylacetate is the ester of a phenol and acetic acid. It is a metabolite of anticancer drug phenylbutyrate (PB), natural neurotransmitter phenylethylamine. Naturally, it is an odorant found in strawberries, passion fruit, and black tea. Phenylacetate level in urine was used as a marker for the diagnosis of some forms of unipolar major depressive disorders. Phenylacetate is used as a tool substrate to study esterase activity in the blood of patients in clinical studies of the effect of nutritional supplements on paraoxonase-1 levels.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3167 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12729627 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Macrophages are essential for lymphocyte infiltration in formyl peptide-induced cholangitis in rat liver. | 1999 Jun |
|
Hydrolysis of platelet-activating factor by human serum paraoxonase. | 2001 Feb 15 |
|
Aspirin. An ab initio quantum-mechanical study of conformational preferences and of neighboring group interactions. | 2001 Feb 9 |
|
Tyrosine and phenylalanine catabolism by Lactobacillus cheese flavor adjuncts. | 2001 May |
|
Species- and substrate-specific stimulation of human plasma paraoxonase 1 (PON1) activity by high chloride concentration. | 2002 |
|
Olfactory discrimination ability for aromatic odorants as a function of oxygen moiety. | 2002 Jan |
|
Monitoring of enzymatic hydrolysis of penicillin G by pyrolysis-negative ion mass spectrometry. | 2002 Jul 1 |
|
[The effects of paraoxonase-1 and oxidized low density lipoprotein on nephropathy in type-2 diabetes mellitus]. | 2002 Mar |
|
Fast, easy, and efficient method for the purification of phenolic isomers using a selective solid-phase scavenging process. | 2002 Nov-Dec |
|
The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1(R192) from PON1(Q192). | 2003 |
|
Europium ion catalyzed methanolysis of esters at neutral pH and ambient temperature. catalytic Involvement of Eu3+(CH3O-)(CH3OH)x. | 2003 Jan 13 |
|
Observation of an arsenic adduct in an acetyl esterase crystal structure. | 2003 Jan 17 |
|
Environmental fate and bioavailability of Agent Orange and its associated dioxin during the Vietnam War. | 2004 |
|
Purification, substrate specificity, and N-terminal amino acid sequence analysis of a beta-lactamase-free penicillin amidase from Alcaligenes sp. | 2004 Aug |
|
[Decrease of paraoxonase activity in the first day after abdominal operations in women]. | 2004 Jul |
|
A new class of acyclic 2-alkyl-1,1,2-triaryl (Z)-olefins as selective cyclooxygenase-2 inhibitors. | 2004 Nov 18 |
|
Isolation of three new naturally occurring compounds from the culture of Micromonospora sp. P1068. | 2005 Oct |
|
Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks. | 2006 |
|
Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes. | 2006 Aug |
|
Polymer supported vanadium and molybdenum complexes as potential catalysts for the oxidation and oxidative bromination of organic substrates. | 2006 Aug 7 |
|
High yield recombinant penicillin G amidase production and export into the growth medium using Bacillus megaterium. | 2006 Nov 28 |
|
Nanostructured biosensor for measuring neuropathy target esterase activity. | 2007 Jul 15 |
|
Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus. | 2007 Jun |
|
The distribution of esterases in the skin of the minipig. | 2007 Sep 10 |
|
Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis. | 2008 Apr |
|
Simple procedures for purification and stabilization of human serum paraoxonase-1. | 2008 Apr 24 |
|
Topical ocular delivery of NSAIDs. | 2008 Jun |
|
Molecular basis of halorespiration control by CprK, a CRP-FNR type transcriptional regulator. | 2008 Oct |
|
Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. | 2008 Oct 16 |
|
Effect of 7Li radiation on endogenous hormonal level on developing cotton fiber. | 2008 Sep |
|
Modulation of butyrate transport in Caco-2 cells. | 2009 Apr |
|
Determinants of variation in human serum paraoxonase activity. | 2009 Feb |
|
Synthesis and evaluation of in vitro antiviral activity of novel phenoxy acetic acid derivatives. | 2009 Jun |
|
High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease. | 2009 Nov |
|
In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes. | 2009 Nov 17 |
|
Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes. | 2009 Nov 3 |
|
Developmental changes in PON1 enzyme activity in young children and effects of PON1 polymorphisms. | 2009 Oct |
|
Effect of loading rate and HRT on the removal of cephalosporin and their intermediates during the operation of a membrane bioreactor treating pharmaceutical wastewater. | 2009 Sep |
|
Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat. | 2009 Sep 9 |
|
3-(4-(Benzo[d]thiazol-2-yl)-1-phenyl-1H-pyrazol-3-yl) phenyl acetate induced Hep G2 cell apoptosis through a ROS-mediated pathway. | 2010 Feb 12 |
|
A comparison of the in vitro biotransformation of (-)-epicatechin and procyanidin B2 by human faecal microbiota. | 2010 Jun |
|
Synthesis of cholesterol-conjugated magnetic nanoparticles for purification of human paraoxonase 1. | 2010 Oct |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15576850
Arylesterase activity was measured as the rate of hydrolysis of phenylacetate into phenol. This process can be detected spectrophotometrically. Serum samples were prepared in sample buffer consisting of 20 mM Tris and 0.9 mM CaCl2 (pH 8.0) in a 40-fold dilution. Five ul of diluted serum was then added to 200 ul of freshly made substrate buffer containing 1 mM phenylacetate, 20 mM Tris, and 0.9 mM CaCl2. The reaction was monitored on a microtiter plate at 260 nm in a Fluostar microplate reader at 37°C. The nonenzymatic hydrolysis of phenylacetate, based on the hydrolysis rate in the absence of serum, was subtracted from the total rate of hydrolysis.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:04:28 GMT 2023
by
admin
on
Fri Dec 15 15:04:28 GMT 2023
|
Record UNII |
355G9R500Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
77993
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
||
|
FDA ORPHAN DRUG |
110698
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
||
|
NCI_THESAURUS |
C1934
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
||
|
FDA ORPHAN DRUG |
11385
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
||
|
LOINC |
75062-0
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
||
|
JECFA EVALUATION |
PHENYL ACETATE
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
122-79-2
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
70619
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID3051626
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
8082
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
204-575-0
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
m8649
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
C1501
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
605
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
SUB181406
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
PHENYL ACETATE
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
2667
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
31229
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
27795
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
18401
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
355G9R500Y
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
100000167072
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY |